SCHEMBL5789658

SCHEMBL5789658

COc1ccc[c]c1-c1ccc(SC)c(Cl)c1

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
DHODH Q02127 1/20 0.32
PTGS2 P35354 2/20 0.32
POLB P06746 1/20 0.31
FPR2 P25090 1/20 0.31
AR P10275 1/20 0.31
ALDH1A1 P00352 2/20 0.31
PTGS1 P23219 1/20 0.31
GRIA1 P42261 1/20 0.31
CACNG8 Q8WXS5 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
TSHR P16473 1/20 0.30
HPGD P15428 1/20 0.30
HSD17B10 Q99714 1/20 0.30
SLC6A4 P31645 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5791789 0.85 ALDH1A1 (0.32) MEN1KMT2ADHODHALDH1A1
SCHEMBL5787468 0.84 NPC1 (0.37) KMT2APTGS2ALDH1A1PTGS1NPC1
SCHEMBL5788870 0.83 AR (0.33) NQO2POLBFPR2ARTSHR
SCHEMBL5789499 0.83 PTGS2 (0.39) MEN1KMT2APTGS2ALDH1A1PTGS1
SCHEMBL5790039 0.83 PTGS2 (0.34) PTGS2AR
SCHEMBL5789885 0.81 RARA (0.32) PTGS2POLBFPR2ARALDH1A1
SCHEMBL5789902 0.78 NQO2 (0.31) NQO2
SCHEMBL5790699 0.77 NPC1 (0.33) ALDH1A1NPC1RAB9A
SCHEMBL10562502 0.76 CYP1A2 (0.43) PTGS2
SCHEMBL5788969 0.76 POLB (0.32) MEN1KMT2APOLBTSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1660500-A1 SUBSTITUTED IMIDAZOPYRIMIDINES FOR THE PREVENTION AND TREATMENT OF CANCER LABORATORIOS S.A.L.V.A.T., S.A. (ES) 2006-05-31 EP claimed
WO-2005014598-A1 SUBSTITUTED IMIDAZOPYRIMIDINES FOR THE PREVENTION AND TREATMENT OF CANCER LABORATORIOS S.A.L.V.A.T., S.A. (ES) 2005-02-17 WO claimed
EP-1660500-A1 SUBSTITUTED IMIDAZOPYRIMIDINES FOR THE PREVENTION AND TREATMENT OF CANCER LABORATORIOS S.A.L.V.A.T., S.A. (ES) 2006-05-31 EP disclosed
WO-2005014598-A1 SUBSTITUTED IMIDAZOPYRIMIDINES FOR THE PREVENTION AND TREATMENT OF CANCER LABORATORIOS S.A.L.V.A.T., S.A. (ES) 2005-02-17 WO disclosed